The Use of 2% Chlorhexidine Gluconate With Mineral Trioxide Aggregate in Indirect Pulp Treatment of Primary Molars

Sponsor
King Abdulaziz University (Other)
Overall Status
Completed
CT.gov ID
NCT04770792
Collaborator
(none)
40
1
2
26.1
1.5

Study Details

Study Description

Brief Summary

The aim of this study was to compare the clinical and radiographic success rates of indirect pulp treatment (IPT) performed by combining 2% chlorhexidine gluconate with mineral trioxide aggregate (MTA) versus IPT performed with MTA in children's vital primary molars. A randomized, split-mouth design including 40 children aged 4-8 years was implemented. The study sample composed of 80 primary molars with deep carious lesions. Each child had 1 pair, one tooth from each pair was allocated randomly either to the 2% chlorhexidine gluconate/MTA group or the MTA group. All teeth were restored with stainless steel crowns. Follow-up is carried out to evaluate the teeth clinically and radiographically.

Condition or Disease Intervention/Treatment Phase
  • Other: 2% chlorhexidine gluconate with mineral trioxide aggregate.
  • Other: Mineral trioxide aggregate.
N/A

Detailed Description

A double blinded, randomized, controlled clinical trial was performed in a split-mouth design. Eighty primary molars in forty subjects were randomly allocated that each subject had one tooth treated with 2% chlorhexidine gluconate and MTA (experimental group), and the other tooth treated with only MTA (control group).

The study was held at King Abdulaziz University Dental Hospital (KAUDH), Jeddah. Forty healthy children with the age range 4- to 8-year-old were included. Each patient had at least two first primary molars or two second primary molars with deep occlusal or proximal caries not approaching the pulp indicated for IPT.

Preoperative periapical radiographs of the teeth considered for treatment in the study were made using extension cone paralleling technique in the x ray machine.

The procedure was performed in two visits by one operator to allow for the setting of MTA. Stainless steel crowns were used as final restorations.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Use of 2% Chlorhexidine Gluconate With Mineral Trioxide Aggregate in Indirect Pulp Treatment of Primary Molars: A Randomized Controlled Clinical Trial
Actual Study Start Date :
Apr 6, 2019
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Jun 8, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group

2% chlorhexidine gluconate with mineral trioxide aggregate.

Other: 2% chlorhexidine gluconate with mineral trioxide aggregate.
2% chlorhexidine gluconate with mineral trioxide aggregate.

Active Comparator: Control group

Mineral trioxide aggregate.

Other: Mineral trioxide aggregate.
Mineral trioxide aggregate.

Outcome Measures

Primary Outcome Measures

  1. Data Recording Sheet for Intraoral Clinical Examination [12 months]

    Data sheet for recording the clinical outcome criteria obtained by intraoral clinical examination is filled by the investigators. The data sheet includes information regarding the presence or absence of the following: Spontaneous pain. Pain on percussion. Signs of abscess or fistula. Abnormal mobility. The response for each point is interpreted in the form by either "yes" or "no".

  2. Data Recording Sheet for Periapical Radiographic Evaluation [12 months]

    Data sheet for recording the radiographic outcome criteria obtained from periapical radiograph is filled by the investigators. The data sheet includes information regarding the presence or absence of the following: Radiolucency at the periapical or interradicular areas. Loss of lamina dura. Signs of internal root resorption. Signs of external pathologic root resorption. Normal root resorption accompanying the exfoliation process. The response for each point is interpreted in the form by either "yes" or "no".

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 8 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Patient inclusion criteria:
  • 4-8 years old.

  • Healthy.

  • Cooperative.

  • Had at least two first primary molars or two second primary molars with deep occlusal or proximal caries not approaching the pulp indicated for IPT.

Teeth inclusion criteria:
  • No spontaneous pain.

  • No pain on palpation or percussion.

  • No signs of fistula or abscess.

  • No abnormal mobility.

  • No radiolucency at the periapical or interradicular areas.

  • No loss of lamina dura.

  • No radiographic signs of internal resorption.

  • Sufficient tooth structure allowing placement of rubber dam.

  • Not expected to exfoliate within 1 year.

Exclusion Criteria:
  • Spontaneous pain.

  • Pain on palpation or percussion.

  • Signs of fistula or abscess.

  • Presence of abnormal mobility.

  • Radiolucency at the periapical or interradicular areas.

  • Loss of lamina dura.

  • Radiographic signs of internal resorption.

  • No sufficient tooth structure allowing placement of rubber dam.

  • Expected to exfoliate within 1 year.

Contacts and Locations

Locations

Site City State Country Postal Code
1 King Abdulaziz University Jeddah Makkah Saudi Arabia Jeddah 21589

Sponsors and Collaborators

  • King Abdulaziz University

Investigators

  • Principal Investigator: Afnan M Saber, MSc, Phd student at Pediatric Dentistry Department, Faculty of Dentistry, King Abdulaziz University.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Afnan Saber, Principle investigator, King Abdulaziz University
ClinicalTrials.gov Identifier:
NCT04770792
Other Study ID Numbers:
  • ASaber
First Posted:
Feb 25, 2021
Last Update Posted:
Sep 16, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Afnan Saber, Principle investigator, King Abdulaziz University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2021